KR20120130180A - 미생물의 포자화에 수반하는 모세포 분해효소를 이용한 유기물의 분해방법 - Google Patents
미생물의 포자화에 수반하는 모세포 분해효소를 이용한 유기물의 분해방법 Download PDFInfo
- Publication number
- KR20120130180A KR20120130180A KR1020127021805A KR20127021805A KR20120130180A KR 20120130180 A KR20120130180 A KR 20120130180A KR 1020127021805 A KR1020127021805 A KR 1020127021805A KR 20127021805 A KR20127021805 A KR 20127021805A KR 20120130180 A KR20120130180 A KR 20120130180A
- Authority
- KR
- South Korea
- Prior art keywords
- decomposition
- decomposed
- group
- bacteria
- spores
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 111
- 239000011368 organic material Substances 0.000 title claims description 11
- 230000000593 degrading effect Effects 0.000 title description 26
- 244000005700 microbiome Species 0.000 title description 15
- 230000015572 biosynthetic process Effects 0.000 title description 11
- 102000004317 Lyases Human genes 0.000 title description 3
- 108090000856 Lyases Proteins 0.000 title description 3
- 210000000130 stem cell Anatomy 0.000 title description 3
- 102000004190 Enzymes Human genes 0.000 claims abstract description 125
- 108090000790 Enzymes Proteins 0.000 claims abstract description 125
- 239000000126 substance Substances 0.000 claims abstract description 60
- 241001148470 aerobic bacillus Species 0.000 claims abstract description 24
- 210000002768 hair cell Anatomy 0.000 claims abstract description 13
- 230000007910 cell fusion Effects 0.000 claims abstract description 11
- 230000028070 sporulation Effects 0.000 claims abstract description 10
- 230000002101 lytic effect Effects 0.000 claims abstract description 9
- 238000000354 decomposition reaction Methods 0.000 claims description 217
- 241000894006 Bacteria Species 0.000 claims description 75
- 210000004027 cell Anatomy 0.000 claims description 60
- 238000003756 stirring Methods 0.000 claims description 47
- 238000005273 aeration Methods 0.000 claims description 45
- 238000010438 heat treatment Methods 0.000 claims description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 22
- 239000005416 organic matter Substances 0.000 claims description 20
- 230000029087 digestion Effects 0.000 claims description 17
- 241000222518 Agaricus Species 0.000 claims description 16
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 claims description 12
- 229920005610 lignin Polymers 0.000 claims description 10
- 239000004009 herbicide Substances 0.000 claims description 9
- 239000001913 cellulose Substances 0.000 claims description 8
- 229920002678 cellulose Polymers 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 230000002363 herbicidal effect Effects 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 5
- 230000035784 germination Effects 0.000 claims description 5
- 240000008397 Ganoderma lucidum Species 0.000 claims description 4
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 4
- 241001327634 Agaricus blazei Species 0.000 claims description 2
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 2
- 235000013527 bean curd Nutrition 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 123
- 239000000243 solution Substances 0.000 description 60
- 239000007788 liquid Substances 0.000 description 46
- 239000000047 product Substances 0.000 description 43
- 229920001436 collagen Polymers 0.000 description 33
- 102000008186 Collagen Human genes 0.000 description 32
- 108010035532 Collagen Proteins 0.000 description 32
- 239000000706 filtrate Substances 0.000 description 31
- 230000015556 catabolic process Effects 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 241000193830 Bacillus <bacterium> Species 0.000 description 22
- 238000006731 degradation reaction Methods 0.000 description 22
- 235000015097 nutrients Nutrition 0.000 description 21
- 210000003491 skin Anatomy 0.000 description 21
- 241000209094 Oryza Species 0.000 description 20
- 235000007164 Oryza sativa Nutrition 0.000 description 20
- 230000004927 fusion Effects 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 20
- 235000009566 rice Nutrition 0.000 description 20
- 230000002132 lysosomal effect Effects 0.000 description 18
- 102000038379 digestive enzymes Human genes 0.000 description 17
- 108091007734 digestive enzymes Proteins 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 239000000843 powder Substances 0.000 description 16
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 15
- 239000001301 oxygen Substances 0.000 description 15
- 229910052760 oxygen Inorganic materials 0.000 description 15
- 230000008569 process Effects 0.000 description 15
- 239000010802 sludge Substances 0.000 description 15
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 13
- 235000017491 Bambusa tulda Nutrition 0.000 description 13
- 241001330002 Bambuseae Species 0.000 description 13
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 13
- 239000011425 bamboo Substances 0.000 description 13
- 235000015277 pork Nutrition 0.000 description 13
- 235000019512 sardine Nutrition 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 210000000988 bone and bone Anatomy 0.000 description 12
- 241000473391 Archosargus rhomboidalis Species 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 10
- 241000192125 Firmicutes Species 0.000 description 10
- 210000002540 macrophage Anatomy 0.000 description 10
- 235000013336 milk Nutrition 0.000 description 10
- 239000008267 milk Substances 0.000 description 10
- 210000004080 milk Anatomy 0.000 description 10
- 241001125048 Sardina Species 0.000 description 9
- 238000000855 fermentation Methods 0.000 description 9
- 230000004151 fermentation Effects 0.000 description 9
- 239000010794 food waste Substances 0.000 description 9
- 239000003446 ligand Substances 0.000 description 9
- 210000004379 membrane Anatomy 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 102000015636 Oligopeptides Human genes 0.000 description 8
- 108010038807 Oligopeptides Proteins 0.000 description 8
- 206010000496 acne Diseases 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 239000010902 straw Substances 0.000 description 8
- 208000002874 Acne Vulgaris Diseases 0.000 description 7
- 241000251468 Actinopterygii Species 0.000 description 7
- 208000003351 Melanosis Diseases 0.000 description 7
- 239000004365 Protease Substances 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 210000004748 cultured cell Anatomy 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 235000019688 fish Nutrition 0.000 description 7
- 150000004676 glycans Chemical class 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- 206010014970 Ephelides Diseases 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 102000004316 Oxidoreductases Human genes 0.000 description 6
- 108090000854 Oxidoreductases Proteins 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 210000004207 dermis Anatomy 0.000 description 6
- 235000003642 hunger Nutrition 0.000 description 6
- 210000002510 keratinocyte Anatomy 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 230000037351 starvation Effects 0.000 description 6
- 239000002699 waste material Substances 0.000 description 6
- 108090000288 Glycoproteins Proteins 0.000 description 5
- 102000003886 Glycoproteins Human genes 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 230000004900 autophagic degradation Effects 0.000 description 5
- 239000002361 compost Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000002023 wood Substances 0.000 description 5
- 108090000625 Cathepsin K Proteins 0.000 description 4
- 102000004171 Cathepsin K Human genes 0.000 description 4
- 108090000624 Cathepsin L Proteins 0.000 description 4
- 102000004172 Cathepsin L Human genes 0.000 description 4
- 241000555825 Clupeidae Species 0.000 description 4
- 102000012422 Collagen Type I Human genes 0.000 description 4
- 108010022452 Collagen Type I Proteins 0.000 description 4
- 102000005927 Cysteine Proteases Human genes 0.000 description 4
- 108010005843 Cysteine Proteases Proteins 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 102000005431 Molecular Chaperones Human genes 0.000 description 4
- 108010006519 Molecular Chaperones Proteins 0.000 description 4
- 108090000526 Papain Proteins 0.000 description 4
- 230000006907 apoptotic process Effects 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 239000007857 degradation product Substances 0.000 description 4
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 239000000446 fuel Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 210000001821 langerhans cell Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 229940055729 papain Drugs 0.000 description 4
- 235000019834 papain Nutrition 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 235000003784 poor nutrition Nutrition 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 210000003934 vacuole Anatomy 0.000 description 4
- 108090000712 Cathepsin B Proteins 0.000 description 3
- 102000004225 Cathepsin B Human genes 0.000 description 3
- 102000004266 Collagen Type IV Human genes 0.000 description 3
- 108010042086 Collagen Type IV Proteins 0.000 description 3
- 108060005980 Collagenase Proteins 0.000 description 3
- 102000029816 Collagenase Human genes 0.000 description 3
- 206010012438 Dermatitis atopic Diseases 0.000 description 3
- 235000019733 Fish meal Nutrition 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 3
- 229920002488 Hemicellulose Polymers 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 206010042496 Sunburn Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 229910052586 apatite Inorganic materials 0.000 description 3
- 201000008937 atopic dermatitis Diseases 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000006037 cell lysis Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940096422 collagen type i Drugs 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000004467 fishmeal Substances 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 210000002865 immune cell Anatomy 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000004719 natural immunity Effects 0.000 description 3
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 235000019419 proteases Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000010865 sewage Substances 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000194107 Bacillus megaterium Species 0.000 description 2
- 241000266830 Bacillus sonorensis Species 0.000 description 2
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 2
- 102100032487 Beta-mannosidase Human genes 0.000 description 2
- 241000193764 Brevibacillus brevis Species 0.000 description 2
- 102000004178 Cathepsin E Human genes 0.000 description 2
- 108090000611 Cathepsin E Proteins 0.000 description 2
- 102000000503 Collagen Type II Human genes 0.000 description 2
- 108010041390 Collagen Type II Proteins 0.000 description 2
- 102000001187 Collagen Type III Human genes 0.000 description 2
- 108010069502 Collagen Type III Proteins 0.000 description 2
- 241001478312 Comamonas sp. Species 0.000 description 2
- 241000252233 Cyprinus carpio Species 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 2
- 241000568397 Lysinibacillus Species 0.000 description 2
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000002469 basement membrane Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 108010055059 beta-Mannosidase Proteins 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- -1 diglyceride Chemical compound 0.000 description 2
- 210000003278 egg shell Anatomy 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 210000004602 germ cell Anatomy 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 150000003408 sphingolipids Chemical class 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 108060007951 sulfatase Proteins 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- HLXHCNWEVQNNKA-UHFFFAOYSA-N 5-methoxy-2,3-dihydro-1h-inden-2-amine Chemical compound COC1=CC=C2CC(N)CC2=C1 HLXHCNWEVQNNKA-UHFFFAOYSA-N 0.000 description 1
- 102100026802 72 kDa type IV collagenase Human genes 0.000 description 1
- 241001519451 Abramis brama Species 0.000 description 1
- 241000920645 Acanthaster Species 0.000 description 1
- 102000006772 Acid Ceramidase Human genes 0.000 description 1
- 108020005296 Acid Ceramidase Proteins 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 241001147780 Alicyclobacillus Species 0.000 description 1
- 101710196855 Aliphatic amidase Proteins 0.000 description 1
- 102100034561 Alpha-N-acetylglucosaminidase Human genes 0.000 description 1
- 108700023418 Amidases Proteins 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 241000555286 Aneurinibacillus Species 0.000 description 1
- 241001626813 Anoxybacillus Species 0.000 description 1
- 241001468259 Anoxybacillus flavithermus Species 0.000 description 1
- 102000009133 Arylsulfatases Human genes 0.000 description 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
- 102000035101 Aspartic proteases Human genes 0.000 description 1
- 108091005502 Aspartic proteases Proteins 0.000 description 1
- 108010023546 Aspartylglucosylaminase Proteins 0.000 description 1
- 241000258957 Asteroidea Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000193408 Bacillus badius Species 0.000 description 1
- 241000193416 Bacillus benzoevorans Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000193414 Bacillus fastidiosus Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 241000193399 Bacillus smithii Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 241000555281 Brevibacillus Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 102000003908 Cathepsin D Human genes 0.000 description 1
- 108090000258 Cathepsin D Proteins 0.000 description 1
- 108090000617 Cathepsin G Proteins 0.000 description 1
- 102000004173 Cathepsin G Human genes 0.000 description 1
- 108090000619 Cathepsin H Proteins 0.000 description 1
- 102000004175 Cathepsin H Human genes 0.000 description 1
- 108090000613 Cathepsin S Proteins 0.000 description 1
- 102100035654 Cathepsin S Human genes 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 241000589519 Comamonas Species 0.000 description 1
- 241000235863 Comamonas denitrificans Species 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 241000579497 Falsibacillus pallidus Species 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 102100028496 Galactocerebrosidase Human genes 0.000 description 1
- 108010042681 Galactosylceramidase Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- 241000193419 Geobacillus kaustophilus Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 241001468249 Geobacillus thermocatenulatus Species 0.000 description 1
- 241001468175 Geobacillus thermodenitrificans Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010017544 Glucosylceramidase Proteins 0.000 description 1
- 102000004547 Glucosylceramidase Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 101000627872 Homo sapiens 72 kDa type IV collagenase Proteins 0.000 description 1
- 101000990915 Homo sapiens Stromelysin-1 Proteins 0.000 description 1
- 241000193404 Hydrogenibacillus schlegelii Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 102000004627 Iduronidase Human genes 0.000 description 1
- 108010003381 Iduronidase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 241000006384 Jeotgalibacillus marinus Species 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 241001134775 Lysinibacillus fusiformis Species 0.000 description 1
- 241001472591 Lysinibacillus sp. Species 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 241001595898 Monophlebidae Species 0.000 description 1
- 208000002678 Mucopolysaccharidoses Diseases 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 102100021003 N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241001615905 Nemopilema nomurai Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 241001072230 Oceanobacillus Species 0.000 description 1
- 241000179039 Paenibacillus Species 0.000 description 1
- 241000178961 Paenibacillus alvei Species 0.000 description 1
- 241001310335 Paenibacillus lentimorbus Species 0.000 description 1
- 241000178960 Paenibacillus macerans Species 0.000 description 1
- 241000194105 Paenibacillus polymyxa Species 0.000 description 1
- 241001310339 Paenibacillus popilliae Species 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 101710111478 Serine protease hepsin Proteins 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 108010061312 Sphingomyelin Phosphodiesterase Proteins 0.000 description 1
- 241000193395 Sporosarcina pasteurii Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102100030416 Stromelysin-1 Human genes 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102000005262 Sulfatase Human genes 0.000 description 1
- 241001134777 Sulfobacillus Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241001291204 Thermobacillus Species 0.000 description 1
- 241000321595 Ureibacillus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 102000010126 acid sphingomyelin phosphodiesterase activity proteins Human genes 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
- 108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
- 102000019199 alpha-Mannosidase Human genes 0.000 description 1
- 108010012864 alpha-Mannosidase Proteins 0.000 description 1
- 108010015684 alpha-N-Acetylgalactosaminidase Proteins 0.000 description 1
- 102000002014 alpha-N-Acetylgalactosaminidase Human genes 0.000 description 1
- 108010009380 alpha-N-acetyl-D-glucosaminidase Proteins 0.000 description 1
- 102000005922 amidase Human genes 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000011382 collagen catabolic process Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008380 degradant Substances 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 108010083141 dipeptidyl carboxypeptidase Proteins 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002270 exclusion chromatography Methods 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 108010089932 heparan sulfate sulfatase Proteins 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 206010028093 mucopolysaccharidosis Diseases 0.000 description 1
- 229940051921 muramidase Drugs 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
- C12P7/08—Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate
- C12P7/10—Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate substrate containing cellulosic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
- B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
- B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
- B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
- B09B5/00—Operations not covered by a single other subclass or by a single other group in this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Environmental & Geological Engineering (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Botany (AREA)
- Immunology (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Dentistry (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Processing Of Solid Wastes (AREA)
Abstract
유기물을 분해하는 방법으로서, 분해 대상이 되는 유기물을 준비하는 공정과, 상기 유기물에, 유포자 호기성 세균의 포자형성에 따른 세포융해에서 발생하는 모세포 융해효소군을 적용하는 공정을 구비하는 것을 특징으로 한다.
Description
도2는, 본 발명의 1실시형태에 있어서 「정어리」를 분해했을 때의 분해 차이를 나타내는 그래프이다.
도3은, 본 발명의 1실시형태에 있어서 「돼지고기」」를 분해했을 때의 분해 비교를 나타내는 그래프이다.
도4는, 본 발명의 1실시형태에 있어서 「돼지고기」」를 분해했을 때의 분해 차이를 나타내는 그래프이다.
도5는, 본 발명의 1실시형태에 있어서 「아가리쿠스 버섯」을 분해했을 때의 분해 비교를 나타내는 그래프이다.
도6은, 본 발명의 1실시형태에 있어서 「아가리쿠스 버섯」을 분해했을 때의 분해 차이를 나타내는 그래프이다.
도7은, 본 발명의 1실시형태에 있어서 「아가리쿠스 버섯」을 분해한 분해 생성물의 분자량 분포를 나타내는 그래프이다.
도8은, 본 발명의 1실시형태에 있어서, 「도미의 비늘」을 분해했을 때의 분해 비교를 나타내는 그래프이다.
도9는, 본 발명의 1실시형태에 있어서, 「도미의 비늘」을 분해했을 때의 분해 차이를 나타내는 그래프이다.
도10은, 본 발명의 1실시형태에 있어서, 「도미의 비늘」을 분해한 분해 생성물의 분자량 분포를 나타내는 그래프이다.
정어리 | |||
일수 | 배양액 | MRE 여과액 | 분해차 |
0 | 100% | 100% | 0.00 |
1 | 92.3% | 54.2% | 0.38 |
2 | 66.7% | 30.5% | 0.36 |
3 | 43.6% | 15.3% | 0.28 |
4 | 20.5% | 0% | 0.21 |
5 | 0% | 0% | 0 |
6 | 0% | 0% | 0 |
돼지고기 | |||
일수 | 배양액 | MRE 여과액 | 분해차 |
0 | 100% | 100% | 0 |
1 | 74.0% | 43.2% | 0.31 |
2 | 48.8% | 21.4% | 0.27 |
3 | 34.4% | 11.1% | 0.23 |
4 | 22.3% | 5.4% | 0.17 |
5 | 19.8% | 0% | 0 |
6 | 14.0% | 0% | 0 |
돼지고기/평균 | MRE 여과액 |
54.4 | 20.5 | 8.2 | 4.7 | 2.3 | 0.3 | 0.0 |
배양액 | 54.4 | 40.2 | 25.6 | 17.2 | 10.5 | 8.8 | 6.8 | |
5 | MRE 여과액 |
51.3 | 23.0 | 9.5 | 5.7 | 2.2 | 0.0 | 0.0 |
배양액 | 51.0 | 38.4 | 24.2 | 18.4 | 10.0 | 9.0 | 7.0 | |
4 | MRE 여과액 |
58.2 | 20.5 | 8.1 | 5.2 | 0.8 | 0.0 | 0.0 |
배양액 | 57.0 | 38.4 | 24.1 | 14.5 | 8.8 | 6.4 | 5.2 | |
3 | MRE 여과액 |
60.0 | 23.5 | 8.6 | 2.4 | 1.3 | 0.0 | 0.0 |
배양액 | 61.0 | 43.2 | 25.7 | 16.6 | 11.5 | 10.0 | 8.0 | |
2 | MRE 여과액 |
57.8 | 20.5 | 8.8 | 6.8 | 5.1 | 1.7 | 0.0 |
배양액 | 60.0 | 48.2 | 32.8 | 21.9 | 12.8 | 10.0 | 8.0 | |
1 | MRE 여과액 |
44.8 | 15.0 | 6.1 | 3.2 | 1.9 | 0.0 | 0.0 |
배양액 | 43.0 | 32.4 | 21.0 | 14.6 | 9.3 | 8.5 | 6.0 | |
돼지고기 | 일수 | 0 | 1 | 2 | 3 | 4 | 5 | 6 |
돼지고기/평균 | MRE 여과액 |
100.0% | 37.7% | 15.1% | 8.6% | 4.2% | 0.6% | 0.0% |
배양액 | 100.0% | 73.9% | 47.0% | 31.6% | 19.3% | 16.1% | 12.6% | |
5 | MRE 여과액 |
100.0% | 44.8% | 18.5% | 11.1% | 4.3% | 0.0% | 0.0% |
배양액 | 100.0% | 75.3% | 47.5% | 36.1% | 19.6% | 17.6% | 13.7% | |
4 | MRE 여과액 |
100.0% | 35.2% | 13.9% | 8.9% | 1.4% | 0.0% | 0.0% |
배양액 | 100.% | 67.4% | 42.3% | 25.4% | 15.4% | 11.2% | 9.1% | |
3 | MRE 여과액 |
100.0% | 39.2% | 14.3% | 4.0% | 2.2% | 0.0% | 0.0% |
배양액 | 100.0% | 70.8% | 42.1% | 27.2% | 18.9% | 16.4% | 13.1% | |
2 | MRE 여과액 |
100.0% | 35.5% | 15.2% | 11.8% | 8.8% | 2.9% | 0.0% |
배양액 | 100.0% | 80.3% | 54.7% | 36.5% | 21.3% | 16.7% | 13.3% | |
1 | MRE 여과액 |
100.0% | 33.5% | 13.6% | 7.1% | 4.2% | 0.0% | 0.0% |
배양액 | 100.0% | 76.0% | 48.8% | 34.0% | 21.6% | 19.8% | 14.0% | |
돼지고기 | 일수 | 0 | 1 | 2 | 3 | 4 | 5 | 6 |
돼지고기 | 1 | 2 | 3 | 4 | 5 | 평균 |
일수 | 차이 | 차이 | 차이 | 차이 | 차이 | 차이 |
1 | 42.6% | 44.9% | 31.7% | 32.1% | 30.5% | 36.2% |
2 | 35.2% | 39.4% | 27.8% | 28.4% | 28.9% | 31.9% |
3 | 26.8% | 24.7% | 23.2% | 16.5% | 25.0% | 23.1% |
4 | 17.4% | 12.5% | 16.7% | 14.1% | 15.3% | 15.1% |
5 | 0.0% | 13.7% | 0.0% | 0.0% | 0.0% | 3.0% |
6 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
아가리쿠스 버섯 | |||
일수 | 배양액 | MRE 여과액 | 분해차 |
0 | 100% | 100% | 0.00 |
2 | 94.5% | 72.0% | 0.22 |
5 | 72.1% | 58.5% | 0.14 |
10 | 48.0% | 34.6% | 0.13 |
16 | 9.5% | 0% | 0.09 |
도미의 비늘 | |||
일수 | 배양액 | MRE 여과액 | 분해차 |
0 | 100% | 100% | 0.00 |
2 | 98.4% | 85.2% | 0.14 |
5 | 95.9% | 85.0% | 0.11 |
10 | 91.7% | 82.1% | 0.10 |
16 | 89.1% | 78.0% | 0.11 |
22 | 86.4% | 68.5% | 0.18 |
Claims (12)
- 유기물(有機物)을 분해하는 방법으로서,
분해 대상이 되는 유기물을 준비하는 공정과,
상기 유기물에, 유포자 호기성 세균(有胞子 好氣性 細菌)의 포자형성에 따른 세포융해에서 발생하는 모세포 융해효소군(母細胞融解酵素群)을 적용하는 공정
을 구비하는 것을 특징으로 하는 방법.
- 제1항에 있어서,
상기 유포자 호기성 세균은, 내생포자(內生胞子; endospore)를 형성하는 복수의 호기성 세균으로 이루어지는 혼합균군(混合菌群)인
것을 특징으로 하는 방법.
- 제2항에 있어서,
상기 혼합균군은, MRE공생균군(共生菌群)인
것을 특징으로 하는 방법.
- 제1항에 있어서,
이 방법은,
상기 유기물에, 상기 유포자 호기성 세균의 포자형성에 의해 생성된 포자를 적용하는 공정을 더 구비하고,
상기 포자는, 발아(發芽) 및 재포자화(再胞子化) 함으로써 모세포 융해효소군을 생성하는 것인
것을 특징으로 하는 방법.
- 제4항에 있어서,
상기 분해 대상의 유기물은, 상기 모세포 융해효소군 및/또는 포자를 함유하는 분해 용액에 침지(浸漬)시키고, 당해 용액을 에어레이션(aeration) 함으로써 분해되는 것인
것을 특징으로 하는 방법.
- 제5항에 있어서,
상기 분해 대상의 유기물은, 영지(靈芝), 아가리쿠스 버섯(Agaricus Blazei Murill), 동충하초(冬蟲夏草), 차가버섯(Chaga), 어린(魚鱗)으로 이루어지는 군으로부터 선택되는 것이며,
이들의 분해 생성물은, 자연면역 활성 조성물(自然免疫活性組成物)로서 사용하기 위한 것인
것을 특징으로 하는 방법.
- 제6항에 있어서,
상기 분해 대상의 유기물은, 어린이며,
이 어린의 분해 생성물은, 자연면역 활성 미용액(自然免疫活性美容液)으로서 사용하기 위한 것인
것을 특징으로 하는 방법.
- 제4항에 있어서,
상기 분해 대상의 유기물은, 60도~80도의 조건하에 있어서 공기 존재 하에서 교반(攪拌)되고, 또한 상기 모세포 융해효소군 및/또는 포자를 함유하는 분해 용액이 산포(散布) 됨으로써 분해되는 것인
것을 특징으로 하는 방법.
- 제8항에 있어서,
이 방법은,
왕겨, 톱밥으로 이루어지는 군으로부터 선택되는 리그닌(lignin) 고함유물(高含有物)을 유동층(fluid bed)으로서 적용하는 공정을 더 구비하는
것을 특징으로 하는 방법.
- 제8항에 있어서,
이 방법은,
분해조(分解槽)로서, 이 분해조는, 가로축의 회전축을 구비하고, 당해 회전축에 교반판이 고정된 1 또는 그 이상의 팔이 설치되고, 상기 교반판이 그리는 궤적에 따라 가열판을 설치하도록 구성되는, 상기 분해조와,
상기 가열판을 60도~160도로 온도 조정 가능한 히터와,
상기 분해조의 상부에 설치되고, 상기 모세포 융해효소군 및/또는 포자를 함유하는 분해 용액을 산포하는 노즐
을 구비하는 장치를 사용해서 이루어지는
것을 특징으로 하는 방법.
- 제8항에 있어서,
상기 분해 대상의 유기물은, 비지이며,
이 비지의 분해 생성물은, 제초제(除草劑)로서 사용하기 위한 것인
것을 특징으로 하는 방법.
- 제8항에 있어서,
상기 분해 대상의 유기물은, 적어도 리그닌과 셀룰로오스(cellulose)를 포함하는 재료이며,
이 재료의 분해 생성물은, 에탄올 원료로서 사용하기 위한 것인
것을 특징으로 하는 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30173710P | 2010-02-05 | 2010-02-05 | |
US61/301,737 | 2010-02-05 | ||
PCT/JP2011/052553 WO2011096567A1 (ja) | 2010-02-05 | 2011-02-07 | 微生物の胞子化に伴う母細胞分解酵素を利用した有機物の分解方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120130180A true KR20120130180A (ko) | 2012-11-29 |
KR101744509B1 KR101744509B1 (ko) | 2017-06-08 |
Family
ID=44355559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020127021805A KR101744509B1 (ko) | 2010-02-05 | 2011-02-07 | 미생물의 포자화에 수반하는 모세포 분해효소를 이용한 유기물의 분해방법 |
Country Status (9)
Country | Link |
---|---|
US (1) | US9102957B2 (ko) |
EP (1) | EP2532448B1 (ko) |
JP (1) | JP5308542B2 (ko) |
KR (1) | KR101744509B1 (ko) |
CN (1) | CN102740986B (ko) |
AU (1) | AU2011211640B2 (ko) |
CA (1) | CA2788949C (ko) |
HK (1) | HK1176579A1 (ko) |
WO (1) | WO2011096567A1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9828612B2 (en) * | 2011-05-23 | 2017-11-28 | Meisho Co., Ltd. | Method for producing alcohol using tree as starting material and alcohol solution obtained by same |
WO2013116830A1 (en) * | 2012-02-03 | 2013-08-08 | Thermocyclomics, Llc | Bioremediation of persistent organic pollutants using thermophilic bacteria |
JP2014001151A (ja) * | 2012-06-15 | 2014-01-09 | Hokkaido Environment Bio Sector Co Ltd | 抗菌消臭剤 |
CN104785508A (zh) * | 2015-05-07 | 2015-07-22 | 上海德瑾绿水科技有限公司 | 用于餐厨垃圾生化降解处理的荞麦壳菌床及其制备使用方法 |
CN109504622B (zh) * | 2018-11-16 | 2022-01-07 | 广东植物龙生物技术股份有限公司 | 一种赖氨酸芽孢杆菌和枯草芽孢杆菌的复合菌剂及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3273301B2 (ja) | 1994-12-22 | 2002-04-08 | 鐐三 入江 | 汚水処理方法 |
JPH10137727A (ja) * | 1996-11-14 | 1998-05-26 | Matsushita Electric Ind Co Ltd | 生ゴミ粉砕発酵処理装置 |
JPH10245290A (ja) * | 1997-03-05 | 1998-09-14 | Akira Kawai | 有機質液体肥料の製造方法 |
JP3768694B2 (ja) | 1997-08-18 | 2006-04-19 | コーア株式会社 | Bacillussp代謝物含有材の製造方法 |
JP3146305B2 (ja) | 1999-06-01 | 2001-03-12 | 株式会社三六九 | 好熱性種菌、並びに有機肥料、液状有機肥料、及びそれらの製造方法 |
JP5260814B2 (ja) * | 2001-09-20 | 2013-08-14 | 株式会社大川原製作所 | 機能性コンポストの製造方法 |
KR100437103B1 (ko) * | 2002-02-08 | 2004-06-23 | 최동성 | 유기물 분해효소를 생산하는 슈도모나스 속 fk916 균주및 이를 이용한 유기 폐기물의 처리방법 |
JP2003284586A (ja) * | 2002-03-28 | 2003-10-07 | Jellice Co Ltd | コラーゲンペプチドの製造方法およびコラーゲンペプチド利用製品の製造方法 |
CN100393672C (zh) * | 2005-06-15 | 2008-06-11 | 湖南大学 | 一种促进农业废物堆肥腐熟的活性添加剂及其应用 |
CN101240313B (zh) * | 2008-03-07 | 2011-06-01 | 陈成 | 一种鱼鳞胶原蛋白肽的制备方法 |
CN101564081B (zh) | 2008-04-25 | 2012-12-05 | 上海创博生态工程有限公司 | 一种利用发酵工艺生产鱼粉替代物产品的制作方法 |
CA2786891C (en) * | 2009-02-20 | 2017-08-01 | Meisho.Co.,Ltd | Immunopotentiating composition and process for producing same |
-
2011
- 2011-02-07 JP JP2011552858A patent/JP5308542B2/ja active Active
- 2011-02-07 EP EP11739914.7A patent/EP2532448B1/en active Active
- 2011-02-07 US US13/576,921 patent/US9102957B2/en active Active
- 2011-02-07 CN CN201180008227.5A patent/CN102740986B/zh active Active
- 2011-02-07 WO PCT/JP2011/052553 patent/WO2011096567A1/ja active Application Filing
- 2011-02-07 KR KR1020127021805A patent/KR101744509B1/ko active IP Right Grant
- 2011-02-07 AU AU2011211640A patent/AU2011211640B2/en active Active
- 2011-02-07 CA CA2788949A patent/CA2788949C/en active Active
-
2013
- 2013-04-02 HK HK13103994.5A patent/HK1176579A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2788949A1 (en) | 2011-08-11 |
EP2532448A4 (en) | 2014-06-11 |
KR101744509B1 (ko) | 2017-06-08 |
AU2011211640B2 (en) | 2015-08-13 |
WO2011096567A1 (ja) | 2011-08-11 |
CA2788949C (en) | 2017-12-12 |
CN102740986A (zh) | 2012-10-17 |
US20120301929A1 (en) | 2012-11-29 |
AU2011211640A1 (en) | 2012-09-20 |
EP2532448B1 (en) | 2016-12-28 |
EP2532448A1 (en) | 2012-12-12 |
JPWO2011096567A1 (ja) | 2013-06-13 |
CN102740986B (zh) | 2014-12-31 |
HK1176579A1 (en) | 2013-08-02 |
US9102957B2 (en) | 2015-08-11 |
JP5308542B2 (ja) | 2013-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9394513B2 (en) | Method for fermentation and cultivation, fermented plant extract, fermented plant extract powder, and composition containing the extract of fermented plant | |
EP2859797A1 (en) | Additive composition for shrimp feed and a method for producing the same | |
KR101744509B1 (ko) | 미생물의 포자화에 수반하는 모세포 분해효소를 이용한 유기물의 분해방법 | |
KR100894528B1 (ko) | 스킨케어 촉진제 | |
KR100344755B1 (ko) | 면역력증강물질및그제조방법 | |
CN104800094B (zh) | 一种防妊娠纹腹膜 | |
KR101750522B1 (ko) | 녹용 추출물을 유효성분으로 하는 에센스 화장료 조성물 | |
JP3428356B2 (ja) | 生理活性物質及びその製造方法 | |
KR20130112401A (ko) | 미강 발효 추출액의 제조방법 및 이 미강 발효 추출액을 함유하는 화장료 조성물 | |
KR102395146B1 (ko) | 농작물 성장촉진 비료제조방법 | |
JP6209580B2 (ja) | 紫外線障害低減剤、紫外線障害低減剤の製造方法、培地用添加剤、微生物希釈液用添加剤、培地、微生物希釈液、外用剤および化粧品 | |
KR100377112B1 (ko) | 건강음료의 제조방법 | |
CN108208811A (zh) | 一种蛹虫草果蔬酵素的制备方法 | |
JP5737896B2 (ja) | 化粧料 | |
KR102626239B1 (ko) | 성게알 가수분해물 또는 성게알 가수분해 발효물을 포함하는, 주름개선 및 피부재생 기능성을 갖는 화장료 조성물과 이의 제조방법 | |
KR102404748B1 (ko) | 피부 진피층으로 투과율 및 체내 흡수율이 개선된 나노 사이즈 저분자 콜라겐 펩타이드의 제조방법 | |
KR102404381B1 (ko) | 유효성분 강화 농산물 재배방법 | |
KR102427750B1 (ko) | 엠에스엠을 이용한 농산물 재배방법 | |
WO2024090464A1 (ja) | 発酵エキスを主原料とする皮膚改善剤 | |
JP2000041623A (ja) | エリンギ菌糸体エキスの製造方法 | |
KR20250003290A (ko) | 동애등에를 함유하는 사료 첨가제 제조방법 및 이에 의한 사료 첨가제 | |
CN117883353A (zh) | 石斛发酵液的制备和应用 | |
KR20180015855A (ko) | 청송꽃돌 발효조성물 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0105 | International application |
Patent event date: 20120821 Patent event code: PA01051R01D Comment text: International Patent Application |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20151110 Comment text: Request for Examination of Application |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20170523 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20170601 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20170601 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20200511 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20210420 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20220407 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20240507 Start annual number: 8 End annual number: 8 |